TABLE 4

Relative ratio of intestinal to hepatic CLint for 16 pathways investigated

Hepatic and intestinal microsome CLint values normalized for the P450 relative abundance and corrected for enterocyte isolation method activity differences.


Substrate

CLtot

CLHIM/CLHLM
HLM
HIM
μl/min/pmol P450 %
1′-Hydroxymidazolam 5.8 5.2 90
4-Hydroxymidazolam 0.38 0.8 210
3-Hydroxydiazepam 0.07 0.022 31
Nordiazepam 0.15 0.11 73
3-Hydroxyflunitrazepam 0.08 0.04 50
Desmethylflunitrazepam 0.1 0.12 120
1′-Hydroxyalprazolam 0.002 0.002 100
4-Hydroxyalprazolam 0.05 0.01 20
1′-Hydroxytriazolam 0.19 0.05 26
4-Hydroxytriazolam 0.14 0.06 43
Quinidine 0.06 0.05 83
Testosterone 0.44 0.60 136
Nifedipine 0.49 0.30 61
Mephenytoin 0.1 0.05 50
Tolbutamide 0.06 0.02 33
Bufuralol
3.2
2.8
88